iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by GFS Advisors LLC

GFS Advisors LLC raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 34.9% in the 4th quarter, Holdings Channel reports. The firm owned 2,259 shares of the financial services provider’s stock after purchasing an additional 585 shares during the quarter. GFS Advisors LLC’s holdings in iShares Biotechnology ETF were worth $299,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Huntington National Bank grew its position in shares of iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares during the last quarter. National Bank of Canada FI boosted its stake in iShares Biotechnology ETF by 5.9% in the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after acquiring an additional 229 shares during the period. First Financial Bank Trust Division bought a new position in shares of iShares Biotechnology ETF during the third quarter valued at approximately $204,000. Thrive Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $445,000. Finally, Avior Wealth Management LLC lifted its holdings in shares of iShares Biotechnology ETF by 438.2% in the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after purchasing an additional 2,629 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $138.66 on Friday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The stock has a fifty day moving average price of $136.37 and a 200 day moving average price of $141.63.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.